Trapeziometacarpal Joint Arthroplasty Versus Trapeziectomy for Thumb Carpometacarpal Osteoarthritis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSahlgrenska University Hospital

About this trial

Thumb carpometacarpal osteoarthritis is common and may cause severe pain and functional limitation. Trapeziectomy is widely used, whereas prosthetic arthroplasty may offer faster early recovery. However, detailed information on early postoperative and long-term radiological outcomes remains limited.

This is a single-centre, blinded randomised controlled trial at Sahlgrenska University Hospital, Gothenburg, Sweden. Adults aged 18-69 years with symptomatic thumb carpometacarpal osteoarthritis (Eaton grade 2-3) refractory to at least 3 months of non-operative treatment will be randomised 1:1 to trapeziometacarpal prosthetic arthroplasty or trapeziectomy. The primary outcome is day-by-day pain (registration on a numeric rating scale NRS, 0-10). Secondary outcomes include day-by-day analgesic consumption for 90 days, orthosis use after cast removal, patient-reported function (HQ-8, QuickDASH, and Nelson score) at 30, 45, 60, 75 and 90 days, assessor-measured range of motion and strength at 45 and 90 days, and long-term clinical follow-up at 6 months and 1, 2, 5 and 10 years. Cone beam computed tomography will be obtained in the arthroplasty group at 1 week postoperatively as reference and at 6 months and 1, 2, 5 and 10 years to assess implant position, migration and loosening. The target sample size is 64 participants (32 per group), providing 95% power to detect a 1-point between-group difference on the pain scale. Analyses will follow the intention-to-treat principle.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Pain at the base of the thumb affecting activities of daily living and insufficient response to at least 3 months of non-operative treatment (orthosis, non-steroidal anti-inflammatory drugs, and/or corticosteroid injections).

Radiographic thumb carpometacarpal osteoarthritis, Eaton grade 2-3.

For Eaton grade 2, age ≥50 years.

Age 18-69 years.

Disqualifiers

Symptomatic osteoarthritis of adjacent joints (e.g., scaphotrapeziotrapezoid joint, STT-joint).

Need for concurrent surgery in the metacarpophalangeal joint (e.g. arthrodesis or capsulodesis).

Post-traumatic thumb carpometacarpal osteoarthritis.

Previous surgery for thumb carpometacarpal osteoarthritis in the contralateral hand.

Trial design

Design model

Parallel

Treatments tested in this trial

  • trapeziometacarpal arthroplasty

    Procedure/Surgery

    Participants allocated to arthroplasty will undergo implantation of the Touch® CMC-1 prosthesis according to routine practice at the study site. Surgery will be performed by experienced hand surgeons. Postoperatively, the thumb will be immobilised in a thumb spica cast that leaves the interphalangeal joint free.

  • Trapeziectomy

    Procedure/Surgery

    Participants allocated to trapeziectomy will undergo surgical excision of the trapezium without tendon interposition according to routine practice at the study site. Postoperatively, the thumb will be immobilised in a thumb spica cast that leaves the interphalangeal joint free

Treatment groups

64 Participants
are divided into 2 treatment groups
Group A: Trapeziometacarpal joint arthroplastyExperimental treatment 1 intervention
Group B: TrapeziectomyActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Pain level

Patient-reported pain at the thumb base, measured on a 0-10 numeric rating scale (0 = no pain, 10 = worst imaginable pain).

Time frame
daily for three months

Secondary outcomes

1

Analgesics used

Daily registration of analgesic consumption

Time frame
daily for three months
2

Use of Orthosis

• Orthosis use and perceived importance recorded weekly after cast removal

Time frame
Daily for three months
3

Patient-reported thumb symptoms

measured with Nelson score (a disease specific questionnaire)

Time frame
at 30, 45, 60, 75 and 90 postoperative days
4

Patient-reported upper extremity function

measured with QuickDASH questionnaire

Time frame
at 30, 45, 60, 75 and 90 postoperative days

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sahlgrenska University Hospital

Lead sponsor

Vastra Gotaland Region

Collaborator

This trial is not recruiting at the moment. You can still explore other options: